Dharmacon, INC
Doing business as Dharmacon
At a glance
Employees100-499
In business sinceNot reported
HeadquartersLafayette, CO
US patents115
SAM.gov UEIJ79FTPM4SHJ5
CAGE code3BY54
Incorporated inDE
- reagents
- functional genomics
- CRISPR guide RNA
- Cas9 nucleases
- gene editing
- gene knockdown
- gene expression
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
115 US patents granted 2003–2018, none of them in the five years to SEP 2025.
Biotechnology 72Pharmaceuticals 40Organic fine chemistry 2Computer technology 1
- Templates, libraries, kits and methods for generating moleculesUS 9,988,625 · granted JUN 5, 2018
- Duplex oligonucleotide complexes and methods for gene silencing by RNA interferenceUS 8,501,706 · granted AUG 6, 2013
- SiRNA targeting connective tissue growth factor (CTGF)US 8,461,326 · granted JUN 11, 2013
- SiRNA targeting apolipoprotein (APOB)US 8,445,668 · granted MAY 21, 2013
- SiRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)US 8,445,667 · granted MAY 21, 2013
Newest 5 shown · Granted to Dharmacon, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Dharmacon, INC | Lafayette | CO | 100–499 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.